Innovus Pharmaceuticals Inc. (fka INNV)

[TheBioTechG]

You seem to be a little behind, so let's bring you up to speed:

FlutiCare is the #1 selling prescription nasal spray:

insert-text-here

The company's FlutiCare™ active is the #1 nasal steroid prescribed by physicians and used by patients with more than After dispensing more than 177 million units since 2007, According to a report by Fierce Pharma, GSK's Flonase OTC sold over $100,000M in a short period of time from its launch confirming the size of the market and the potential of FlutiCare™ if approved by the FDA.

Innovus bought the rights to FlutiCare OTC and is awaiting FDA ANDa approval.

FlutiCare has brand recognition and would be a competing force in the $1B nasal spray OTC market.